logo

For the Inventor, By the Inventor

Flagstaff, AZ, United States of America

Paul Christopher Begovac

USPTO Granted Patents = 11

Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 274(Granted Patents)


Company Filing History:

goldMedal10 out of 1,626 
 
W. L. Gore & Associates, Inc.
 patents
where one patent can have more than one assignee

Years Active: 1982-2023

Loading Chart...
11 patents (USPTO):Explore Patents
1. 11752099 - Injectable and biodegradable polymer formulations for controlled release of bioactive agents (2023-09-12),
2. 11497838 - Immobilised biological entities (2022-11-15),
3. 10736999 - Immobilised biological entities (2020-08-11),
4. 9764068 - Immobilised biological entities (2017-09-19),
5. 9408950 - Immobilised biological entities (2016-08-09),
6. 9101696 - Immobilised biological entities (2015-08-11),
7. 9005269 - Bioabsorbable self-expanding endolumenal devices (2015-04-14),
8. 5908449 - Blood contact surfaces using extracellular matrix synthesized in vitro (1999-06-01),
9. 5879383 - Blood contact surfaces using endothelium on a subendothelial matrix (1999-03-09),
10. 5716394 - Blood contact surfaces using extracellular matrix synthesized in vitro (1998-02-10),
11. 4321914 - Percutaneous conduit having PTFE skirt (1982-03-30),

Title: Innovations of Paul Christopher Begovac

Introduction

Paul Christopher Begovac is a notable inventor based in Flagstaff, AZ, with a remarkable portfolio of 11 patents. His work primarily focuses on the development of innovative biomedical solutions that enhance the delivery of bioactive agents.

Latest Patents

One of his latest patents is titled "Injectable and biodegradable polymer formulations for controlled release of bioactive agents." This patent describes injectable formulations that utilize biodegradable polymers based on trimethylene carbonate (TMC) combined with polylactic acid (PLA) and/or polyglycolic acid (PGA). These formulations are designed to deliver bioactive agents to targeted sites effectively. The inclusion of excipients such as polyethylene glycol (PEG) helps to reduce injection force and modulate the release of the bioactive agent. Additionally, suitable biodegradable polymers for these formulations include various combinations of D,L-PLA:TMC, D-PLA:TMC, L-PLA:TMC, and TMC:PLA:PGA. Another significant patent involves "Immobilised biological entities," which describes a device featuring a layered coating with cationic hyperbranched polymer molecules. These molecules possess specific molecular weight characteristics and functional end groups that can be covalently attached to anti-coagulant entities.

Career Highlights

Paul is currently employed at W. L. Gore & Associates, Inc., where he contributes to the advancement of medical technologies. His innovative approaches have led to significant improvements in the field of drug delivery systems.

Collaborations

Throughout his career, Paul has collaborated with esteemed colleagues, including Karin Leontein and Per Antoni, to further enhance the impact of his inventions.

Conclusion

Paul Christopher Begovac's contributions to the field of biomedical engineering through his patents and collaborations highlight his commitment to innovation and improving healthcare solutions. His work continues to pave the way for advancements in drug delivery technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…